Page last updated: 2024-11-13
actinobolin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
actinobolin: active against broad spectrum of bacteria & variety of rodent neoplasms; minor descriptor (75-85); on-line & Index Medicus search ANTIBIOTICS (75-85); RN given refers to (3R- (3alpha,4alpha(S*),4abeta,5beta,6alpha))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 54688606 |
| CHEMBL ID | 1984390 |
| SCHEMBL ID | 309793 |
| MeSH ID | M0263057 |
Synonyms (21)
| Synonym |
|---|
| isocoumarin,4,4a,5,6,7-hexahydro-5,6,8-trihydroxy-3-methyl- |
| nsc-31083 |
| actinobolin |
| propanamide,4,4a,5,6,7-hexahydro-5,6,8-trihydroxy-3-methyl-1-oxo-1h-2-benzopyran-4-yl)-, [3r-[3.alpha.,4.alpha.(s*),4a.beta.,5.beta.,6.alpha.]]- |
| NSC31083 , |
| 24397-89-5 |
| NCI60_002679 |
| isocoumarin, 4-(2-aminopropionamido)-3,4,4a,5,6,7-hexahydro-5,6,8-trihydroxy-3-methyl- |
| 4-(2-aminopropionamido)-3,4,4a,5,6,7-hexahydro-5,6,8-trihydroxy-3-methylisocoumarin |
| nsc 31083 |
| propanamide, 2-amino-n-(3,4,4a,5,6,7-hexahydro-5,6,8-trihydroxy-3-methyl-1-oxo-1h-2-benzopyran-4-yl)-, (3r-(3alpha,4alpha(s*),4abeta,5beta,6alpha))- |
| unii-999317a21f |
| 999317a21f , |
| SCHEMBL309793 |
| propanamide, 2-amino-n-((3r,4r,4ar,5r,6r)-3,4,4a,5,6,7-hexahydro-5,6,8-trihydroxy-3-methyl-1-oxo-1h-2-benzopyran-4-yl)-, (2s)- |
| (+)-actinobolin |
| actinobolin [mi] |
| CHEMBL1984390 |
| Q27272192 |
| (s)-2-amino-n-((3r,4r,4ar,5r,6r)-5,6,8-trihydroxy-3-methyl-1-oxo-3,4,4a,5,6,7-hexahydro-1h-isochromen-4-yl)propanamide |
| DTXSID001043243 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 20.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.56) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 17 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||